Everything you care about in one place
Follow feeds: blogs, news, RSS and more. An effortless way to read and digest content of your choice.
Get Feedergoogle.co.in
Google Alert - dupilumab
Get the latest updates from Google Alert - dupilumab directly as they happen.
Follow now 112 followers
Latest posts
Last updated about 3 hours ago
Mount Sinai researchers are testing if dupilumab, used for asthma, can help prevent lung ...
about 9 hours ago
Mount Sinai Department of Medicine (@DOMSinaiNYC). 23 views. Mount Sinai researchers are...
Dupilumab Shows Higher 2-Year Drug Survival Than Other Targeted Therapies for Atopic Dermatitis
about 11 hours ago
Dupilumab shows superior 2-year drug survival rates in atopic dermatitis compared to...
La SEAIC inaugura su nueva sede en Madrid
about 12 hours ago
... dupilumab, el primer tratamiento biológico disponible en España. Con prevalencias al...
Long‐term efficacy and safety of stapokibart for moderate‐to‐severe atopic dermatitis
about 13 hours ago
Dupilumab provides important clinical benefits to patients with atopic dermatitis who do...
A Rare Case of Dupilumab Monotherapy in Pemphigoid Nodularis and a Comprehensive ...
about 14 hours ago
Dupilumab, a fully human monoclonal antibody that binds to the IL-4 receptor...
When Hypereosinophilia occurs during dupilumab therapy: evidence-based strategies for ...
about 15 hours ago
1. Dupilumab is a monoclonal antibody which selectively targets T2 inflammation by...
Abrocitinib versus dupilumab: Impact on skin barrier function and proteomics in atopic dermatitis
about 16 hours ago
Abrocitinib versus dupilumab: Impact on skin barrier function and proteomics in atopic...
Dupilumab holds potential for treating hand eczema in moderate-to-severe atopic dermatitis
about 16 hours ago
Dupilumab holds potential for treating hand eczema in moderate-to-severe atopic dermatitis. Primary...
Pharma Pulse: Amgen's Uplizna Secures CD19 Approval for Myasthenia Gravis, as Asthma ...
about 17 hours ago
While agents like dupilumab and tezepelumab showed strong persistence, the need for...
国产JAK1抑制剂艾玛昔替尼临床试验启动，高选择性成关注焦点 - 新药情报库
about 22 hours ago
近日，一款国产创新药物的最新动态为广大患者带来了希望。这款充满期待的药物是由知名药企恒瑞医药自主研发的高选择性JAK1抑制剂——艾玛昔替尼，商品名艾速达® ...
Arcus与吉利德调整研发战略，停止TIGIT联合试验 - 新药情报库
about 22 hours ago
2025年12月12日，生物技术公司Arcus Biosciences正式宣布，由于其3期临床试验未能取得预期效果，将中止与吉利德科学公司合作开发的抗TIGIT抗体药物domvanalimab ...
Dupilumab Is Effective for Atopic Dermatitis - NEJM Clinician
1 day ago
Standard AD care was continued, including use of topical steroids and, if...